Evidence-based consensus recommendations published by experts in the management of disease are a critical fiber of the healthcare fabric. Healthcare providers rely on guidelines and expert recommendations to inform treatment decisions and insurance providers rely on these to design formularies. Researchers compare new therapeutic or procedural interventions to standard-of-care practice guidelines in randomized controlled trials. However, many diseases still lack up-to-date recommendations or expert consensus recommendations, resulting in wide variability in practice patterns, and leaving many patients without access to treatment they need. Evidence-based guidelines and expert consensus best practice recommendations are lacking for many pediatric skin diseases.
To help address this need, PeDRA is calling for submissions to its 2022 Consensus Grant program, which will provide up to $25,000 of support for the creation of consensus recommendations, best practice recommendations, or consensus treatment plans for the treatment of diseases in the field of pediatric dermatology in the United States and/or Canada. Interested teams are invited to submit proposals to create consensus-based recommendations or best practice recommendations for a disease of their choice, using a rigorous methodology of their choice. However, priority will be given to proposals that address diseases for which contemporary guidelines do not exist, and which use established consensus methodology.
- Up to $25,000 for one year to support the creation of consensus recommendations or best practice recommendations for the management of diseases in the field of pediatric dermatology
- Applications due Thursday, December 1, 2022
Past Consensus Grant Recipients:
Nanette Silverberg, MD
2021 Consensus Grant
Icahn School of Medicine at Mount Sinai
Pediatric and Adolescent Vitiligo Guidelines
Alex Zvulunov, MD & Elena Pope, MD, MsC
2019 Consensus Guidelines Award
Consensus-based recommendations for management of pediatric Mycosis Fungoides: the ARMFUL (AppRoach Mycosis FUngoides in chiLdren) study